CFI-402257
CAS No. 1610759-22-2
CFI-402257 ( —— )
Catalog No. M27538 CAS No. 1610759-22-2
CFI-402257 is a orally active, and potent highly selective small-molecule inhibitor of Mps1 with Ki of 0.09 ± 0.02 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 446 | Get Quote |
|
10MG | 550 | Get Quote |
|
25MG | 878 | Get Quote |
|
50MG | 1314 | Get Quote |
|
100MG | 1773 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCFI-402257
-
NoteResearch use only, not for human use.
-
Brief DescriptionCFI-402257 is a orally active, and potent highly selective small-molecule inhibitor of Mps1 with Ki of 0.09 ± 0.02 nM.
-
DescriptionCFI-402257 is a orally active, and potent highly selective small-molecule inhibitor of Mps1 with Ki of 0.09 ± 0.02 nM.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1610759-22-2
-
Formula Weight498.6
-
Molecular FormulaC28H30N6O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Poland T M , Groot P , Haack R A , et al. Evaluation of semiochemicals potentially synergistic to α-pinene for trapping the larger European pine shoot beetle, Tomicus piniperda (Col. Scolytidae)[J]. Journal of Applied Entomology, 2010, 128(9-10):639-644.
molnova catalog
related products
-
CDDO-2P-Im
CDDO-2P-Im, an analog of CDDO-Imidazolide, has a chemopreventive effect. It can reduce the size and severity of the lung tumors in the mouse lung cancer model.
-
BC-1471
BC-1471 is a novel selective antagonist of deubiquitinase STAM-binding protein (STAMBP), decreasing NALP7 protein levels and suppressing IL-1β release after TLR agonism.A small-molecule inhibitor of STAMBP deubiquitinase activity, BC-1471, decreases NALP7 protein levels and suppresses IL-1β release after TLR agonism.?
-
Quercetin 3-O-neohes...
Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.